nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—NCOR1—neck—esophageal cancer	0.0138	0.0534	CbGeAlD
Vorinostat—HDAC1—neck—esophageal cancer	0.0111	0.0429	CbGeAlD
Vorinostat—HDAC8—bronchus—esophageal cancer	0.0109	0.0423	CbGeAlD
Vorinostat—Gastrointestinal toxicity—Capecitabine—esophageal cancer	0.00968	0.0784	CcSEcCtD
Vorinostat—HDAC11—bronchus—esophageal cancer	0.00954	0.0369	CbGeAlD
Vorinostat—HDAC2—exocrine gland—esophageal cancer	0.00872	0.0337	CbGeAlD
Vorinostat—HDAC8—digestive system—esophageal cancer	0.00845	0.0327	CbGeAlD
Vorinostat—HDAC3—bronchus—esophageal cancer	0.00811	0.0314	CbGeAlD
Vorinostat—HDAC6—lung—esophageal cancer	0.00796	0.0308	CbGeAlD
Vorinostat—HDAC1—epithelium—esophageal cancer	0.00755	0.0292	CbGeAlD
Vorinostat—HDAC1—bronchus—esophageal cancer	0.00743	0.0287	CbGeAlD
Vorinostat—HDAC11—digestive system—esophageal cancer	0.00737	0.0285	CbGeAlD
Vorinostat—HDAC9—bronchus—esophageal cancer	0.00731	0.0283	CbGeAlD
Vorinostat—HDAC3—trachea—esophageal cancer	0.00728	0.0282	CbGeAlD
Vorinostat—HDAC1—smooth muscle tissue—esophageal cancer	0.00727	0.0281	CbGeAlD
Vorinostat—Ureteric obstruction—Methotrexate—esophageal cancer	0.0072	0.0584	CcSEcCtD
Vorinostat—Gastrointestinal toxicity—Methotrexate—esophageal cancer	0.0072	0.0584	CcSEcCtD
Vorinostat—NCOR1—digestive system—esophageal cancer	0.00715	0.0276	CbGeAlD
Vorinostat—HDAC8—lung—esophageal cancer	0.00706	0.0273	CbGeAlD
Vorinostat—HDAC4—lung—esophageal cancer	0.00686	0.0265	CbGeAlD
Vorinostat—HDAC1—trachea—esophageal cancer	0.00667	0.0258	CbGeAlD
Vorinostat—HDAC9—trachea—esophageal cancer	0.00656	0.0254	CbGeAlD
Vorinostat—HDAC3—digestive system—esophageal cancer	0.00627	0.0242	CbGeAlD
Vorinostat—HDAC11—lung—esophageal cancer	0.00616	0.0238	CbGeAlD
Vorinostat—NCOR1—lung—esophageal cancer	0.00597	0.0231	CbGeAlD
Vorinostat—HDAC1—digestive system—esophageal cancer	0.00574	0.0222	CbGeAlD
Vorinostat—NR0B1—lung—esophageal cancer	0.00561	0.0217	CbGeAlD
Vorinostat—HDAC2—neck—esophageal cancer	0.00558	0.0216	CbGeAlD
Vorinostat—HDAC6—lymph node—esophageal cancer	0.00544	0.021	CbGeAlD
Vorinostat—HDAC3—lung—esophageal cancer	0.00523	0.0202	CbGeAlD
Vorinostat—HDAC8—lymph node—esophageal cancer	0.00483	0.0187	CbGeAlD
Vorinostat—HDAC1—lung—esophageal cancer	0.00479	0.0185	CbGeAlD
Vorinostat—HDAC9—lung—esophageal cancer	0.00472	0.0182	CbGeAlD
Vorinostat—HDAC4—lymph node—esophageal cancer	0.00469	0.0181	CbGeAlD
Vorinostat—Myelosuppression—Cisplatin—esophageal cancer	0.0046	0.0372	CcSEcCtD
Vorinostat—HDAC11—lymph node—esophageal cancer	0.00421	0.0163	CbGeAlD
Vorinostat—NCOR1—lymph node—esophageal cancer	0.00408	0.0158	CbGeAlD
Vorinostat—HDAC2—epithelium—esophageal cancer	0.00379	0.0147	CbGeAlD
Vorinostat—HDAC2—bronchus—esophageal cancer	0.00374	0.0144	CbGeAlD
Vorinostat—HDAC2—smooth muscle tissue—esophageal cancer	0.00366	0.0141	CbGeAlD
Vorinostat—HDAC3—lymph node—esophageal cancer	0.00358	0.0138	CbGeAlD
Vorinostat—Serum creatinine increased—Cisplatin—esophageal cancer	0.0035	0.0284	CcSEcCtD
Vorinostat—HDAC1—lymph node—esophageal cancer	0.00328	0.0127	CbGeAlD
Vorinostat—HDAC9—lymph node—esophageal cancer	0.00322	0.0125	CbGeAlD
Vorinostat—HDAC2—digestive system—esophageal cancer	0.00289	0.0112	CbGeAlD
Vorinostat—Abscess—Cisplatin—esophageal cancer	0.00272	0.0221	CcSEcCtD
Vorinostat—Deep vein thrombosis—Capecitabine—esophageal cancer	0.00261	0.0212	CcSEcCtD
Vorinostat—Infection—Carboplatin—esophageal cancer	0.0026	0.0211	CcSEcCtD
Vorinostat—Serum creatinine increased—Capecitabine—esophageal cancer	0.00258	0.0209	CcSEcCtD
Vorinostat—Embolism—Capecitabine—esophageal cancer	0.00247	0.0201	CcSEcCtD
Vorinostat—HDAC2—lung—esophageal cancer	0.00241	0.00932	CbGeAlD
Vorinostat—Body temperature increased—Carboplatin—esophageal cancer	0.00207	0.0168	CcSEcCtD
Vorinostat—Deep vein thrombosis—Methotrexate—esophageal cancer	0.00194	0.0158	CcSEcCtD
Vorinostat—Embolism—Methotrexate—esophageal cancer	0.00184	0.0149	CcSEcCtD
Vorinostat—Proteinuria—Capecitabine—esophageal cancer	0.00181	0.0147	CcSEcCtD
Vorinostat—Protein urine present—Capecitabine—esophageal cancer	0.00178	0.0145	CcSEcCtD
Vorinostat—HDAC2—lymph node—esophageal cancer	0.00165	0.00637	CbGeAlD
Vorinostat—Pulmonary embolism—Capecitabine—esophageal cancer	0.00159	0.0129	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00156	0.0127	CcSEcCtD
Vorinostat—Abscess—Methotrexate—esophageal cancer	0.00149	0.0121	CcSEcCtD
Vorinostat—Blood creatinine increased—Cisplatin—esophageal cancer	0.00147	0.0119	CcSEcCtD
Vorinostat—Dehydration—Cisplatin—esophageal cancer	0.00145	0.0118	CcSEcCtD
Vorinostat—Hypokalaemia—Cisplatin—esophageal cancer	0.00142	0.0115	CcSEcCtD
Vorinostat—Sepsis—Capecitabine—esophageal cancer	0.00138	0.0112	CcSEcCtD
Vorinostat—Proteinuria—Methotrexate—esophageal cancer	0.00135	0.0109	CcSEcCtD
Vorinostat—Protein urine present—Methotrexate—esophageal cancer	0.00133	0.0108	CcSEcCtD
Vorinostat—Pancytopenia—Cisplatin—esophageal cancer	0.00128	0.0104	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00122	0.0099	CcSEcCtD
Vorinostat—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00119	0.00963	CcSEcCtD
Vorinostat—Pulmonary embolism—Methotrexate—esophageal cancer	0.00118	0.00959	CcSEcCtD
Vorinostat—Myocardial infarction—Cisplatin—esophageal cancer	0.00118	0.00958	CcSEcCtD
Vorinostat—Lethargy—Capecitabine—esophageal cancer	0.00118	0.00954	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00115	0.00935	CcSEcCtD
Vorinostat—Blood creatinine increased—Capecitabine—esophageal cancer	0.00108	0.00876	CcSEcCtD
Vorinostat—Dehydration—Capecitabine—esophageal cancer	0.00107	0.00869	CcSEcCtD
Vorinostat—Hypokalaemia—Capecitabine—esophageal cancer	0.00105	0.00851	CcSEcCtD
Vorinostat—Sepsis—Methotrexate—esophageal cancer	0.00103	0.00832	CcSEcCtD
Vorinostat—Alopecia—Cisplatin—esophageal cancer	0.000956	0.00775	CcSEcCtD
Vorinostat—Pancytopenia—Capecitabine—esophageal cancer	0.000946	0.00767	CcSEcCtD
Vorinostat—Neutropenia—Capecitabine—esophageal cancer	0.000932	0.00755	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000926	0.00751	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00091	0.00737	CcSEcCtD
Vorinostat—Muscle spasms—Cisplatin—esophageal cancer	0.000906	0.00734	CcSEcCtD
Vorinostat—Weight decreased—Capecitabine—esophageal cancer	0.000902	0.00731	CcSEcCtD
Vorinostat—Hyperglycaemia—Capecitabine—esophageal cancer	0.000899	0.00729	CcSEcCtD
Vorinostat—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000876	0.0071	CcSEcCtD
Vorinostat—Lethargy—Methotrexate—esophageal cancer	0.000876	0.0071	CcSEcCtD
Vorinostat—Myocardial infarction—Capecitabine—esophageal cancer	0.000871	0.00706	CcSEcCtD
Vorinostat—Anaemia—Cisplatin—esophageal cancer	0.000871	0.00706	CcSEcCtD
Vorinostat—Leukopenia—Cisplatin—esophageal cancer	0.000843	0.00683	CcSEcCtD
Vorinostat—Oedema peripheral—Capecitabine—esophageal cancer	0.000786	0.00637	CcSEcCtD
Vorinostat—Infection—Cisplatin—esophageal cancer	0.000764	0.00619	CcSEcCtD
Vorinostat—Thrombocytopenia—Cisplatin—esophageal cancer	0.000753	0.0061	CcSEcCtD
Vorinostat—Anorexia—Cisplatin—esophageal cancer	0.000733	0.00594	CcSEcCtD
Vorinostat—Chills—Capecitabine—esophageal cancer	0.000716	0.0058	CcSEcCtD
Vorinostat—Alopecia—Capecitabine—esophageal cancer	0.000705	0.00571	CcSEcCtD
Vorinostat—Pancytopenia—Methotrexate—esophageal cancer	0.000705	0.00571	CcSEcCtD
Vorinostat—Neutropenia—Methotrexate—esophageal cancer	0.000694	0.00562	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000689	0.00559	CcSEcCtD
Vorinostat—Dysgeusia—Capecitabine—esophageal cancer	0.00068	0.00551	CcSEcCtD
Vorinostat—Decreased appetite—Cisplatin—esophageal cancer	0.000668	0.00542	CcSEcCtD
Vorinostat—Muscle spasms—Capecitabine—esophageal cancer	0.000668	0.00541	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000664	0.00538	CcSEcCtD
Vorinostat—Anaemia—Capecitabine—esophageal cancer	0.000642	0.0052	CcSEcCtD
Vorinostat—Syncope—Capecitabine—esophageal cancer	0.000623	0.00505	CcSEcCtD
Vorinostat—Leukopenia—Capecitabine—esophageal cancer	0.000622	0.00504	CcSEcCtD
Vorinostat—Loss of consciousness—Capecitabine—esophageal cancer	0.00061	0.00495	CcSEcCtD
Vorinostat—Body temperature increased—Cisplatin—esophageal cancer	0.000608	0.00493	CcSEcCtD
Vorinostat—Cough—Capecitabine—esophageal cancer	0.000606	0.00491	CcSEcCtD
Vorinostat—Chest pain—Capecitabine—esophageal cancer	0.000591	0.00479	CcSEcCtD
Vorinostat—Dry mouth—Capecitabine—esophageal cancer	0.000578	0.00469	CcSEcCtD
Vorinostat—Infection—Capecitabine—esophageal cancer	0.000563	0.00456	CcSEcCtD
Vorinostat—Shock—Capecitabine—esophageal cancer	0.000558	0.00452	CcSEcCtD
Vorinostat—Thrombocytopenia—Capecitabine—esophageal cancer	0.000555	0.0045	CcSEcCtD
Vorinostat—Asthenia—Cisplatin—esophageal cancer	0.000552	0.00447	CcSEcCtD
Vorinostat—Anorexia—Capecitabine—esophageal cancer	0.00054	0.00438	CcSEcCtD
Vorinostat—Chills—Methotrexate—esophageal cancer	0.000533	0.00432	CcSEcCtD
Vorinostat—Diarrhoea—Cisplatin—esophageal cancer	0.000526	0.00426	CcSEcCtD
Vorinostat—Alopecia—Methotrexate—esophageal cancer	0.000525	0.00425	CcSEcCtD
Vorinostat—Dysgeusia—Methotrexate—esophageal cancer	0.000506	0.0041	CcSEcCtD
Vorinostat—Decreased appetite—Capecitabine—esophageal cancer	0.000493	0.00399	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000489	0.00397	CcSEcCtD
Vorinostat—Vomiting—Cisplatin—esophageal cancer	0.000489	0.00396	CcSEcCtD
Vorinostat—Fatigue—Capecitabine—esophageal cancer	0.000489	0.00396	CcSEcCtD
Vorinostat—Constipation—Capecitabine—esophageal cancer	0.000485	0.00393	CcSEcCtD
Vorinostat—Anaemia—Methotrexate—esophageal cancer	0.000478	0.00387	CcSEcCtD
Vorinostat—Leukopenia—Methotrexate—esophageal cancer	0.000463	0.00375	CcSEcCtD
Vorinostat—Nausea—Cisplatin—esophageal cancer	0.000457	0.0037	CcSEcCtD
Vorinostat—Cough—Methotrexate—esophageal cancer	0.000451	0.00366	CcSEcCtD
Vorinostat—Body temperature increased—Capecitabine—esophageal cancer	0.000448	0.00363	CcSEcCtD
Vorinostat—Chest pain—Methotrexate—esophageal cancer	0.00044	0.00357	CcSEcCtD
Vorinostat—Infection—Methotrexate—esophageal cancer	0.000419	0.0034	CcSEcCtD
Vorinostat—Thrombocytopenia—Methotrexate—esophageal cancer	0.000413	0.00335	CcSEcCtD
Vorinostat—Asthenia—Capecitabine—esophageal cancer	0.000407	0.0033	CcSEcCtD
Vorinostat—Anorexia—Methotrexate—esophageal cancer	0.000402	0.00326	CcSEcCtD
Vorinostat—Pruritus—Capecitabine—esophageal cancer	0.000401	0.00325	CcSEcCtD
Vorinostat—Diarrhoea—Capecitabine—esophageal cancer	0.000388	0.00314	CcSEcCtD
Vorinostat—Dizziness—Capecitabine—esophageal cancer	0.000375	0.00304	CcSEcCtD
Vorinostat—Decreased appetite—Methotrexate—esophageal cancer	0.000367	0.00297	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000364	0.00295	CcSEcCtD
Vorinostat—Fatigue—Methotrexate—esophageal cancer	0.000364	0.00295	CcSEcCtD
Vorinostat—Vomiting—Capecitabine—esophageal cancer	0.00036	0.00292	CcSEcCtD
Vorinostat—Headache—Capecitabine—esophageal cancer	0.000355	0.00288	CcSEcCtD
Vorinostat—Nausea—Capecitabine—esophageal cancer	0.000337	0.00273	CcSEcCtD
Vorinostat—Body temperature increased—Methotrexate—esophageal cancer	0.000333	0.0027	CcSEcCtD
Vorinostat—Asthenia—Methotrexate—esophageal cancer	0.000303	0.00245	CcSEcCtD
Vorinostat—Pruritus—Methotrexate—esophageal cancer	0.000298	0.00242	CcSEcCtD
Vorinostat—Diarrhoea—Methotrexate—esophageal cancer	0.000289	0.00234	CcSEcCtD
Vorinostat—Dizziness—Methotrexate—esophageal cancer	0.000279	0.00226	CcSEcCtD
Vorinostat—Vomiting—Methotrexate—esophageal cancer	0.000268	0.00217	CcSEcCtD
Vorinostat—Headache—Methotrexate—esophageal cancer	0.000264	0.00214	CcSEcCtD
Vorinostat—Nausea—Methotrexate—esophageal cancer	0.000251	0.00203	CcSEcCtD
Vorinostat—HDAC1—Signaling Pathways—NOTCH3—esophageal cancer	4.85e-05	7.85e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—NOTCH3—esophageal cancer	4.81e-05	7.78e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—ENO1—esophageal cancer	4.8e-05	7.77e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—FBXW7—esophageal cancer	4.77e-05	7.72e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—NOS2—esophageal cancer	4.76e-05	7.71e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—CDKN1A—esophageal cancer	4.75e-05	7.69e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—HIF1A—esophageal cancer	4.75e-05	7.69e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ELMO1—esophageal cancer	4.74e-05	7.66e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TGFBR2—esophageal cancer	4.74e-05	7.66e-05	CbGpPWpGaD
Vorinostat—HDAC2—Circadian rythm related genes—TP53—esophageal cancer	4.74e-05	7.66e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PSME2—esophageal cancer	4.73e-05	7.66e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PSME1—esophageal cancer	4.73e-05	7.66e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—NOTCH1—esophageal cancer	4.72e-05	7.64e-05	CbGpPWpGaD
Vorinostat—HDAC11—Disease—MYC—esophageal cancer	4.7e-05	7.61e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—CREBBP—esophageal cancer	4.66e-05	7.53e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CREBBP—esophageal cancer	4.65e-05	7.52e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—ERBB2—esophageal cancer	4.65e-05	7.52e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—CREBBP—esophageal cancer	4.64e-05	7.51e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—NOS3—esophageal cancer	4.64e-05	7.51e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—ERBB2—esophageal cancer	4.64e-05	7.51e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—NOTCH1—esophageal cancer	4.64e-05	7.5e-05	CbGpPWpGaD
Vorinostat—HDAC1—Generic Transcription Pathway—MYC—esophageal cancer	4.63e-05	7.49e-05	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—EP300—esophageal cancer	4.63e-05	7.49e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—AKAP13—esophageal cancer	4.63e-05	7.49e-05	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—CREBBP—esophageal cancer	4.61e-05	7.46e-05	CbGpPWpGaD
Vorinostat—HDAC11—Disease—EGFR—esophageal cancer	4.6e-05	7.44e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—KDR—esophageal cancer	4.54e-05	7.35e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CALR—esophageal cancer	4.54e-05	7.35e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—PTGS2—esophageal cancer	4.54e-05	7.34e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—EP300—esophageal cancer	4.52e-05	7.32e-05	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle, Mitotic—MYC—esophageal cancer	4.51e-05	7.3e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—SMAD4—esophageal cancer	4.48e-05	7.25e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—HIF1A—esophageal cancer	4.44e-05	7.19e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.41e-05	7.14e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—FBXW7—esophageal cancer	4.39e-05	7.11e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NOTCH2—esophageal cancer	4.35e-05	7.04e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—ERBB2—esophageal cancer	4.34e-05	7.02e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—NOTCH2—esophageal cancer	4.31e-05	6.98e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—CDKN1A—esophageal cancer	4.3e-05	6.95e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—NOTCH1—esophageal cancer	4.28e-05	6.93e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—CREBBP—esophageal cancer	4.28e-05	6.92e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HIST1H2BM—esophageal cancer	4.27e-05	6.91e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—HIF1A—esophageal cancer	4.27e-05	6.91e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—EGFR—esophageal cancer	4.25e-05	6.88e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—KDR—esophageal cancer	4.25e-05	6.88e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—PTGS2—esophageal cancer	4.24e-05	6.87e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PDE4D—esophageal cancer	4.23e-05	6.85e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CREBBP—esophageal cancer	4.2e-05	6.8e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—NOS3—esophageal cancer	4.17e-05	6.75e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—NOS3—esophageal cancer	4.16e-05	6.74e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—NOS3—esophageal cancer	4.16e-05	6.73e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—NOTCH1—esophageal cancer	4.14e-05	6.7e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—CCND1—esophageal cancer	4.11e-05	6.64e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—EP300—esophageal cancer	4.09e-05	6.62e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.05e-05	6.56e-05	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—MYC—esophageal cancer	4.03e-05	6.53e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—GNG7—esophageal cancer	4.03e-05	6.52e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—NOTCH1—esophageal cancer	4e-05	6.48e-05	CbGpPWpGaD
Vorinostat—HDAC11—Disease—PIK3CA—esophageal cancer	3.99e-05	6.46e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—HIF1A—esophageal cancer	3.99e-05	6.46e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—CDKN1A—esophageal cancer	3.97e-05	6.43e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—CDKN1A—esophageal cancer	3.97e-05	6.42e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—MYC—esophageal cancer	3.94e-05	6.38e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—CREBBP—esophageal cancer	3.9e-05	6.31e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—ERBB2—esophageal cancer	3.9e-05	6.31e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—ERBB2—esophageal cancer	3.89e-05	6.3e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—NOS2—esophageal cancer	3.88e-05	6.29e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CREBBP—esophageal cancer	3.88e-05	6.28e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TGFBR2—esophageal cancer	3.86e-05	6.25e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—EGFR—esophageal cancer	3.85e-05	6.24e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—NOTCH1—esophageal cancer	3.85e-05	6.22e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—NOS3—esophageal cancer	3.83e-05	6.2e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KDR—esophageal cancer	3.82e-05	6.18e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—PTGS2—esophageal cancer	3.81e-05	6.17e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—EP300—esophageal cancer	3.78e-05	6.11e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—EP300—esophageal cancer	3.77e-05	6.11e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—XIAP—esophageal cancer	3.77e-05	6.11e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—NOS3—esophageal cancer	3.76e-05	6.09e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—CREBBP—esophageal cancer	3.76e-05	6.08e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—CDKN1A—esophageal cancer	3.71e-05	6e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—PIK3CA—esophageal cancer	3.69e-05	5.97e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—HIF1A—esophageal cancer	3.67e-05	5.94e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SMAD4—esophageal cancer	3.65e-05	5.91e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CREBBP—esophageal cancer	3.63e-05	5.87e-05	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—PIK3CA—esophageal cancer	3.63e-05	5.87e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—SMAD4—esophageal cancer	3.62e-05	5.86e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NOTCH1—esophageal cancer	3.6e-05	5.82e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—CREBBP—esophageal cancer	3.58e-05	5.8e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—ERBB2—esophageal cancer	3.58e-05	5.8e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CTNNA1—esophageal cancer	3.57e-05	5.77e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—MYC—esophageal cancer	3.56e-05	5.77e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—TGFBR2—esophageal cancer	3.55e-05	5.75e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CXCL2—esophageal cancer	3.55e-05	5.74e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—EP300—esophageal cancer	3.53e-05	5.71e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—ERBB2—esophageal cancer	3.52e-05	5.7e-05	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—TP53—esophageal cancer	3.51e-05	5.68e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KDR—esophageal cancer	3.51e-05	5.68e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—PTGS2—esophageal cancer	3.5e-05	5.67e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—NOS3—esophageal cancer	3.49e-05	5.65e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CREBBP—esophageal cancer	3.49e-05	5.64e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—EGFR—esophageal cancer	3.49e-05	5.64e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—NOS3—esophageal cancer	3.47e-05	5.62e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CCND1—esophageal cancer	3.44e-05	5.57e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—SMAD4—esophageal cancer	3.36e-05	5.44e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—PIK3CA—esophageal cancer	3.34e-05	5.41e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—CDKN1A—esophageal cancer	3.33e-05	5.39e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CDKN1A—esophageal cancer	3.33e-05	5.39e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PSME1—esophageal cancer	3.31e-05	5.36e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PSME2—esophageal cancer	3.31e-05	5.36e-05	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—TP53—esophageal cancer	3.31e-05	5.36e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NOTCH1—esophageal cancer	3.3e-05	5.35e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ANXA1—esophageal cancer	3.3e-05	5.34e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—MYC—esophageal cancer	3.29e-05	5.33e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—MYC—esophageal cancer	3.29e-05	5.32e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CREBBP—esophageal cancer	3.26e-05	5.28e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—ERBB2—esophageal cancer	3.25e-05	5.26e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—NOS3—esophageal cancer	3.25e-05	5.26e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—EGFR—esophageal cancer	3.22e-05	5.21e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—EGFR—esophageal cancer	3.22e-05	5.21e-05	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—MYC—esophageal cancer	3.22e-05	5.2e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SST—esophageal cancer	3.21e-05	5.19e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—NOS3—esophageal cancer	3.21e-05	5.19e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PTGS2—esophageal cancer	3.19e-05	5.17e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—EP300—esophageal cancer	3.17e-05	5.13e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—EP300—esophageal cancer	3.17e-05	5.12e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—EP300—esophageal cancer	3.16e-05	5.12e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—GHRL—esophageal cancer	3.13e-05	5.06e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NOTCH3—esophageal cancer	3.13e-05	5.06e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—NOS3—esophageal cancer	3.12e-05	5.05e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CCND1—esophageal cancer	3.11e-05	5.03e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—MYC—esophageal cancer	3.08e-05	4.98e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FBXW7—esophageal cancer	3.08e-05	4.98e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—CDKN1A—esophageal cancer	3.06e-05	4.96e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—ERBB2—esophageal cancer	3.04e-05	4.92e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—PIK3CA—esophageal cancer	3.03e-05	4.9e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CDKN1A—esophageal cancer	3.01e-05	4.87e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—EGFR—esophageal cancer	3.01e-05	4.87e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CREBBP—esophageal cancer	3e-05	4.85e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—HIF1A—esophageal cancer	2.99e-05	4.84e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PTGS2—esophageal cancer	2.93e-05	4.75e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—ERBB2—esophageal cancer	2.92e-05	4.73e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NOS3—esophageal cancer	2.92e-05	4.72e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—EP300—esophageal cancer	2.91e-05	4.72e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CCND1—esophageal cancer	2.87e-05	4.65e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—EP300—esophageal cancer	2.86e-05	4.63e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KDR—esophageal cancer	2.86e-05	4.63e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PTGS2—esophageal cancer	2.86e-05	4.62e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NOTCH2—esophageal cancer	2.8e-05	4.54e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—PIK3CA—esophageal cancer	2.8e-05	4.52e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—PIK3CA—esophageal cancer	2.79e-05	4.52e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CDKN1A—esophageal cancer	2.78e-05	4.49e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—MYC—esophageal cancer	2.76e-05	4.47e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—MYC—esophageal cancer	2.76e-05	4.47e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—HIF1A—esophageal cancer	2.75e-05	4.45e-05	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—MYC—esophageal cancer	2.73e-05	4.43e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—ERBB2—esophageal cancer	2.73e-05	4.42e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—TP53—esophageal cancer	2.7e-05	4.38e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—EGFR—esophageal cancer	2.7e-05	4.37e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—EGFR—esophageal cancer	2.7e-05	4.37e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NOTCH1—esophageal cancer	2.69e-05	4.36e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CCND1—esophageal cancer	2.69e-05	4.35e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NOS3—esophageal cancer	2.68e-05	4.34e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—NOTCH1—esophageal cancer	2.67e-05	4.32e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—EP300—esophageal cancer	2.66e-05	4.3e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—EP300—esophageal cancer	2.64e-05	4.28e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—PIK3CA—esophageal cancer	2.61e-05	4.23e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CDKN1A—esophageal cancer	2.6e-05	4.2e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—MYC—esophageal cancer	2.54e-05	4.11e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—ERBB2—esophageal cancer	2.51e-05	4.06e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NOS2—esophageal cancer	2.5e-05	4.05e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CDKN1A—esophageal cancer	2.5e-05	4.04e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MYC—esophageal cancer	2.5e-05	4.04e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TGFBR2—esophageal cancer	2.49e-05	4.03e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—EGFR—esophageal cancer	2.48e-05	4.02e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NOTCH1—esophageal cancer	2.48e-05	4.01e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—EP300—esophageal cancer	2.47e-05	4e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CREBBP—esophageal cancer	2.44e-05	3.95e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—EGFR—esophageal cancer	2.44e-05	3.95e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—EP300—esophageal cancer	2.44e-05	3.95e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—CREBBP—esophageal cancer	2.42e-05	3.92e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CCND1—esophageal cancer	2.41e-05	3.9e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—EP300—esophageal cancer	2.38e-05	3.84e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SMAD4—esophageal cancer	2.35e-05	3.81e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—PIK3CA—esophageal cancer	2.35e-05	3.8e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—PIK3CA—esophageal cancer	2.34e-05	3.79e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—PIK3CA—esophageal cancer	2.34e-05	3.78e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CDKN1A—esophageal cancer	2.33e-05	3.78e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MYC—esophageal cancer	2.3e-05	3.73e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TP53—esophageal cancer	2.27e-05	3.67e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TP53—esophageal cancer	2.26e-05	3.66e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—EGFR—esophageal cancer	2.25e-05	3.64e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CREBBP—esophageal cancer	2.25e-05	3.64e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—MYC—esophageal cancer	2.23e-05	3.61e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—EP300—esophageal cancer	2.22e-05	3.59e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CCND1—esophageal cancer	2.22e-05	3.59e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NOS3—esophageal cancer	2.19e-05	3.54e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—PIK3CA—esophageal cancer	2.16e-05	3.49e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MYC—esophageal cancer	2.15e-05	3.49e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CDKN1A—esophageal cancer	2.14e-05	3.47e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—PIK3CA—esophageal cancer	2.12e-05	3.43e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—EGFR—esophageal cancer	2.11e-05	3.41e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MYC—esophageal cancer	2.07e-05	3.35e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TP53—esophageal cancer	2.05e-05	3.32e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—ERBB2—esophageal cancer	2.05e-05	3.31e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—EP300—esophageal cancer	2.04e-05	3.3e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—EGFR—esophageal cancer	2.02e-05	3.28e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NOS3—esophageal cancer	2.01e-05	3.26e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PIK3CA—esophageal cancer	1.96e-05	3.18e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PIK3CA—esophageal cancer	1.95e-05	3.16e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MYC—esophageal cancer	1.93e-05	3.13e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HIF1A—esophageal cancer	1.93e-05	3.12e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—EGFR—esophageal cancer	1.89e-05	3.06e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TP53—esophageal cancer	1.89e-05	3.06e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—ERBB2—esophageal cancer	1.88e-05	3.05e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KDR—esophageal cancer	1.84e-05	2.98e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PTGS2—esophageal cancer	1.84e-05	2.98e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PIK3CA—esophageal cancer	1.83e-05	2.96e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CCND1—esophageal cancer	1.81e-05	2.92e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PIK3CA—esophageal cancer	1.81e-05	2.92e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MYC—esophageal cancer	1.78e-05	2.88e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TP53—esophageal cancer	1.77e-05	2.86e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PIK3CA—esophageal cancer	1.76e-05	2.84e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CDKN1A—esophageal cancer	1.75e-05	2.83e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—EGFR—esophageal cancer	1.74e-05	2.81e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NOTCH1—esophageal cancer	1.74e-05	2.81e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—EP300—esophageal cancer	1.66e-05	2.69e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PIK3CA—esophageal cancer	1.64e-05	2.66e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CDKN1A—esophageal cancer	1.61e-05	2.6e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TP53—esophageal cancer	1.59e-05	2.57e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CREBBP—esophageal cancer	1.57e-05	2.55e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—EP300—esophageal cancer	1.53e-05	2.48e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PIK3CA—esophageal cancer	1.51e-05	2.44e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TP53—esophageal cancer	1.46e-05	2.36e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MYC—esophageal cancer	1.45e-05	2.35e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—MYC—esophageal cancer	1.44e-05	2.32e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—EGFR—esophageal cancer	1.42e-05	2.29e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NOS3—esophageal cancer	1.41e-05	2.28e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MYC—esophageal cancer	1.33e-05	2.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ERBB2—esophageal cancer	1.32e-05	2.13e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—EGFR—esophageal cancer	1.3e-05	2.11e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CA—esophageal cancer	1.23e-05	1.99e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TP53—esophageal cancer	1.19e-05	1.93e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CCND1—esophageal cancer	1.16e-05	1.88e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PIK3CA—esophageal cancer	1.13e-05	1.83e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CDKN1A—esophageal cancer	1.13e-05	1.82e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EP300—esophageal cancer	1.07e-05	1.73e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MYC—esophageal cancer	9.34e-06	1.51e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EGFR—esophageal cancer	9.14e-06	1.48e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CA—esophageal cancer	7.93e-06	1.28e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TP53—esophageal cancer	7.67e-06	1.24e-05	CbGpPWpGaD
